ICICI 3-in-1 Account Login

SMS PHARMACEUTICALS SHARE PRICE

Sector Pharmaceuticals
BSE 532815
NSE SMSPHARMA
262.55
-3.85 (-1.45 %)
Buy
B
Sell
S
NSE BSE

Overview

Day Low

260.30

Day High

271.12

52 Week Low

175.25

52 Week High

398.00

All Time Low

7.40

All Time High

398.00

Open

268.90

Close

266.40

Volume

140,094

Mkt cap (Cr)

2,327.56

P/E ratio

34.76

P/B ratio

0.26%

Div yield

0.15%

6M return

4.83%

1Y return

27.76%

1D 1W 1M 3M 6M 1Yr 3Yr 5Yr 10Yr Max
Price PE Ratio
 

We appreciate your patience. Your content is on the way.

SWOT Analysis

  • S
  • W
  • O
  • T

Technical Analysis

Moving Averages

EMA SMA
 

We appreciate your patience. Your content is on the way.

262.55 -1.45%

Current Price

  • Bullish Moving Averages
  • Bearish Moving Averages

Resistance and support

 

We appreciate your patience. Your content is on the way.

Company Financials

  • Profit and loss statement
  • Balance sheet
  • Quarterly Result
  • Ratio
 

We appreciate your patience. Your content is on the way.

Quick Results Snapshot

 

We appreciate your patience. Your content is on the way.

Shareholding Pattern

Summary

 

We appreciate your patience. Your content is on the way.

 

We appreciate your patience. Your content is on the way.

Historical Promoter Summary

 

We appreciate your patience. Your content is on the way.

Promoter Holding(%)

Historical FII Holdings

 

We appreciate your patience. Your content is on the way.

FII Holding(%)

Historical MF Holdings

 

We appreciate your patience. Your content is on the way.

MF Holding(%)

Stocks Comparison
Table Chart

 

We appreciate your patience. Your content is on the way.

Corporate Action

  • Announcement
  • Board Meeting
  • Dividend
  • Split
  • Rights
  • Events

Insider & Institutional Activity

  • Bulk Block Deals
  • Insider Trading & SAST
 

We appreciate your patience. Your content is on the way.

About SMS Pharmaceuticals Ltd

Stock PE (TTM)

34.76

Promoter Holding

66.26%

Book Value

69.299

ROCE

11.69%

ROE

9.87%

SMS Pharmaceuticals Limited was incorporated in December, 1987. The company is engaged in the business of manufacturing of Active Pharma Ingredients and their intermediates. Apart from R &D Center at Gagillapur, Hyderabad, the company is having manufacturing facilities at Bachupally, Hyderabad and also at Kandivalasa Village in Vijayanagaram District of Andhra Pradesh. Its business activity is a single primary business segment of "Bulk Drugs". During the year 2015, the company has re-enforced its fundamental strength of FDA compliant facilities by successfully completing the US FDA audits at Kandivalasa and Bachupally facilities. During the year 2015, the company filed 9 Drug Master Files and total DMFs filed up to 31 March 2015 are 24. During the year 2014-15, the Company acquired 12,25,900 equity shares of Rs. 10/- each in M/s. VKT Pharma Private Limited. With this the said company has become an associate company. The project of the said associate company is in final stage and at the verge of completion and operations are yet to be commenced. The Company has not having any subsidiaries. During the year 2015-16, the Company had sub divided the face value of share of Rs 10/- each into face value of Rs 1/- of each with record date of 18th December 2015. During FY 2015-16, the Board has approved the "Draft Scheme of Arrangement for Demerger of Semi Regulated Units (Unit - I, IV & V) along with other Assets to transfer the same to SMS Lifesciences India Limited (Resulting Company), with an object to reduce the impact of Semi Regulated Units on Regulated Units, achieving operational efficiencies, site synergies and streamlining its current structure. The Draft Scheme of Arrangement is subject to the Approvals of Stock Exchanges, Securities Board of India Limited, Reserve Bank of India and other regulatory authorities and also Hon`ble High Court of Judicature at Hyderabad for the State of Telangana and Andhra Pradesh. During FY 2016-17, the Company had made investment in it`s associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2016-17, the Company had acquired 5,11,400 equity shares of face value of Rs 10/- each in the said associate at an average price of Rs 157.21. Further, the Company had also made an investment in 1000 equity shares of Sireen Drugs Private Limited of Rs 10/- each. SMS Lifesciences India Limited is the wholly owned subsidiary of the Company during the Financial Year 2016-17. The Semi Regulatory Units of the Company were demerged and transferred to SMS Lifesciences India Limited effective from 01-04-2016 and SMS LifeSciences India Limited was made a Wholly Owned Subsidiary of the Company in 2017. The said Scheme became effective from 17th May, 2017. In terms of the said Scheme, the Company allotted 30,23,287 equity shares of Rs.10/- each to the shareholders of the company on 23rd June, 2017. The Company had made investment in its associate company viz. M/s. VKT Pharma Private Limited for its business purpose. During the year under review 2017-18, the Company had acquired 7,84,100 equity shares of face value of Rs.10/- each in the said associate at an average price of Rs.200.81. During FY 2018-19, the Company had made investment in it`s associate Company viz. M/s. VKT Pharma Private Limited for its business purpose. The Company held 38,50,165 equity shares of Rs 10/- each in VKT Pharma Private Limited as on 31st March 2019 as investments. In 2020-21, the Company incorporated Joint Venture (JV) in Spain with nomenclature of "CHEMO SMS ENTERPRISES SL" in the capital ratio of 55:45. The Ibuprofen product got launched in 2023.

SMS Pharmaceuticals share price as on 20 May 2025 is Rs. 262.55. Over the past 6 months, the SMS Pharmaceuticals share price has increased by 4.83% and in the last one year, it has increased by 27.76%. The 52-week low for SMS Pharmaceuticals share price was Rs. 175.25 and 52-week high was Rs. 398.

Read More
Registered Office  
Registrars  
Management  
Listing Info  

532815

SMSPHARMA

INE812G01025

Sep

SMS Pharmaceuticals Ltd FAQs

You can buy SMS Pharmaceuticals Ltd shares through a brokerage firm. ICICIdirect is a registered broker through which you can place orders to buy SMS Pharmaceuticals Ltd Share.

Company share prices and volatile and keep changing according to the market conditions. As of May 20, 2025 03:59 PM the closing price of SMS Pharmaceuticals Ltd was Rs.262.55.

The latest PE ratio of SMS Pharmaceuticals Ltd as of May 20, 2025 03:59 PM is 34.76

The latest PB ratio of SMS Pharmaceuticals Ltd as of May 20, 2025 03:59 PM is 0.26

The 52-week high of SMS Pharmaceuticals Ltd share price is Rs. 398.00 while the 52-week low is Rs. 175.25

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of May 20, 2025 03:59 PM, the market cap of SMS Pharmaceuticals Ltd stood at Rs. 2,327.56 Cr.

Market Outlook

View all
 

We appreciate your patience. Your content is on the way.